The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289 · cited 1×
“In contrast, full-length mammalian Apaf-1 requires interaction with cytochrome c, which is released from mitochondria during apoptosis, to induce a conformational change that facilitates the binding and activation of procaspase 9 (Boatright, 2003; Li et al., 1997).”
BackgroundThe phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441401 · Cited by 5,243
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 16×
“The second group includes proapoptotic proteins such as Bax and Bak, which also contain multiple BH domains.”
BackgroundInfluentialThe Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Wei, M. C., Zong, W.-X., Cheng, E. H.-Y., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B., & Korsmeyer, S. J. (2001) · Science · doi:10.1126/science.1059108 · Cited by 3,988
BCL-2 family members and the mitochondria in apoptosis
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,288
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
Vaux, D. L., Cory, S., & Adams, J. M. (1988) · Nature · doi:10.1038/335440a0 · Cited by 3,219
Self-citationThe DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., & Nagata, S. (1998) · Nature · doi:10.1038/34112 · Cited by 3,189
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. B. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 2,967
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,925
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
Earnshaw, W. C., Martins, L. M., & Kaufmann, S. H. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.383 · Cited by 2,760
Self-citationProliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 2,724
Biochemical Pathways of Caspase Activation During Apoptosis
Budihardjo, I., Oliver, H., Lutter, M., Luo, X., & Wang, X. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.269 · Cited by 2,565
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372
Self-citationSafety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoellner, U., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011573 · Cited by 2,019
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Slee, E. A., Harte, M. T., Kluck, R. M., Wolf, B. B., Casiano, C. A., Newmeyer, D. D., Wang, H.-G., Reed, J. C., Nicholson, D. W., Alnemri, E. S., et al. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.2.281 · Cited by 1,929
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Liu, X., Zou, H., Slaughter, C., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80197-x · Cited by 1,834
Endonuclease G is an apoptotic DNase when released from mitochondria
Li, L. Y., Luo, X., & Wang, X. (2001) · Nature · doi:10.1038/35083620 · Cited by 1,787 · cited 2×
“Antisense molecules that reduce XIAP levels sensitize non-small cell lung cancer cells to radiation (Holcik et al., 2000) and ovarian cancer cells to cisplatin-induced apoptosis (Li et al., 2001a).”
BackgroundThe c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
Cheng, E. H.-Y. A., Wei, M. C., Weiler, S., Flavell, R. A., Mak, T. W., Lindsten, T., & Korsmeyer, S. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00320-3 · Cited by 1,707
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Caspase structure, proteolytic substrates, and function during apoptotic cell death
Nicholson, D. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400598 · Cited by 1,543
Bouillet, P., Metcalf, D., Huang, D. C. S., Tarlinton, D. M., Kay, T. W. H., Köntgen, F., Adams, J. M., & Strasser, A. (1999) · Science · doi:10.1126/science.286.5445.1735 · Cited by 1,504
Bax-Deficient Mice with Lymphoid Hyperplasia and Male Germ Cell Death
Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Science · doi:10.1126/science.270.5233.96 · Cited by 1,493
Lindsten, T., Ross, A. J., King, A., Zong, W.-X., Rathmell, J. C., Shiels, H. A., Ulrich, E., Waymire, K. G., Mahar, P., Frauwirth, K., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00136-2 · Cited by 1,489
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
Ashkenazi, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc821 · Cited by 1,360
Apoptosis: Mechanisms and Roles in Pathology
ARENDS, M. J., & WYLLIE, A. H. (1991) · International Review of Experimental Pathology · doi:10.1016/b978-0-12-364932-4.50010-1 · Cited by 1,334
Molecular thanatopsis: a discourse on the BCL2 family and cell death
Yang, E., & Korsmeyer, S. (1996) · Blood · doi:10.1182/blood.v88.2.386.bloodjournal882386 · Cited by 1,332
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells
Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., & Vogelstein, B. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00213-1 · Cited by 1,280
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Newmeyer, D. D., & Ferguson-Miller, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00116-8 · Cited by 1,269
Induction of Apoptosis by Cancer Chemotherapy
Kaufmann, S. H., & Earnshaw, W. C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4838 · Cited by 1,266 · cited 5×
“On the other hand, apoptosis induced by radiation, p53, glucocorticoids, cytokine deprivation, and most chemotherapeutic drugs usually leads to apoptosis that involves Apaf-1mediated caspase 9 activation (Kaufmann and Earnshaw, 2000).”
BackgroundInfluentialSelf-citationGreen, D. R., & Evan, G. I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00024-7 · Cited by 1,254 · cited 1×
“In summary, currently available information suggests that the process of carcinogenesis usually requires at least two cellular changes, one inhibiting apoptosis and another that facilitates cell proliferation (Green and Evan, 2002).”
BackgroundMyc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J. S., Mett, I. L., Rebrikov, D., Brodianski, V. M., Kemper, O. C., Kollet, O., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80609-3 · Cited by 1,234
lpr And gld: Single Gene Models Of Systemic Autoimmunity And Lymphoproliferative Disease
Cohen, P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.243 · Cited by 1,196
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Sentman, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., & Korsmeyer, S. J. (1991) · Cell · doi:10.1016/0092-8674(91)90361-2 · Cited by 1,194
Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00073-8 · Cited by 1,172
Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y.-Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138
Slee, E. A., Adrain, C., & Martin, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008363200 · Cited by 1,115
Puthalakath, H., Huang, D. C. S., O’Reilly, L. A., King, S. M., & Strasser, A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80456-6 · Cited by 1,054
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
Strasser, A., Harris, A. W., & Cory, S. (1991) · Cell · doi:10.1016/0092-8674(91)90362-3 · Cited by 1,054
An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif
Crook, N. E., Clem, R. J., & Miller, L. K. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2168-2174.1993 · Cited by 1,053
Disruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044
BH3-Only Proteins—Essential Initiators of Apoptotic Cell Death
Huang, D. C. S., & Strasser, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00187-2 · Cited by 1,043
Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes
Listen, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton-Horvat, G., Farahani, R., McLean, M., lkeda, J.-E., Mackenzie, A., et al. (1996) · Nature · doi:10.1038/379349a0 · Cited by 1,014
Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia
Rai, K. R., Peterson, B. L., Appelbaum, F. R., Kolitz, J., Elias, L., Shepherd, L., Hines, J., Threatte, G. A., Larson, R. A., Cheson, B. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432402 · Cited by 1,001
Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M., & Ashwell, J. D. (2000) · Science · doi:10.1126/science.288.5467.874 · Cited by 988
Dysregulation of Apoptosis in Cancer
Reed, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2941 · Cited by 987
Apoptosis signaling by death receptors
Schulze‐Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., & Peter, M. E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540439.x · Cited by 978
A Unified Model for Apical Caspase Activation
Boatright, K. M., Renatus, M., Scott, F. L., Sperandio, S., Shin, H., Pedersen, I. M., Ricci, J.-E., Edris, W. A., Sutherlin, D. P., Green, D. R., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00051-0 · Cited by 968
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
Soengas, M. S., Capodieci, P., Polsky, D., Mora, J., Esteller, M., Opitz-Araya, X., McCombie, R., Herman, J. G., Gerald, W. L., Lazebnik, Y. A., et al. (2001) · Nature · doi:10.1038/35051606 · Cited by 966
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis
Yeh, W.-C., Pompa, J. L. D. L., McCurrach, M. E., Shu, H.-B., Elia, A. J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., et al. (1998) · Science · doi:10.1126/science.279.5358.1954 · Cited by 893
Caenorhabditis elegans gene ced-9 protects cells from programmed cell death
Hengartner, M. O., Ellis, R., & Horvitz, R. (1992) · Nature · doi:10.1038/356494a0 · Cited by 889
Life-or-death decisions by the Bcl-2 protein family
Adams, J. M., & Cory, S. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01740-0 · Cited by 886
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
Miyashita, T., & Reed, J. (1993) · Blood · doi:10.1182/blood.v81.1.151.151 · Cited by 882
Role of BAX in the Apoptotic Response to Anticancer Agents
Zhang, L., Yu, J., Park, B. H., Kinzler, K. W., & Vogelstein, B. (2000) · Science · doi:10.1126/science.290.5493.989 · Cited by 863 · cited 1×
“Although it has been reported that BAX deletion inhibits drug-induced apoptosis in HCT116 cells in vitro (Zhang et al., 2000; Theodorakis et al., 2002), the effects of this alteration on drug sensitivity in vivo remain to be established.”
BackgroundThe machinery of programmed cell death
Zimmermann, K. C., Bonzon, C., & Green, D. R. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00159-0 · Cited by 833
Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., & Kidd, V. J. (2000) · Nature Medicine · doi:10.1038/75007 · Cited by 811
Cellular stress response and apoptosis in cancer therapy
Herr, I., & Debatin, K.-M. (2001) · Blood · doi:10.1182/blood.v98.9.2603 · Cited by 800
Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.
Strasser, A., Harris, A. W., Huang, D. C., Krammer, P. H., & Cory, S. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00304.x · Cited by 784
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., et al. (1998) · Nature · doi:10.1038/25387 · Cited by 783
Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis
Daugas, E., Susin, S. A., Zamzami, N., Ferri, K. F., Irinopoulou, T., Larochette, N., Prévost, M., Leber, B., Andrews, D., Penninger, J., et al. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.729 · Cited by 776
Fulda, S., Wick, W., Weller, M., & Debatin, K.-M. (2002) · Nature Medicine · doi:10.1038/nm735 · Cited by 741
Puthalakath, H., & Strasser, A. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400998 · Cited by 722
Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization
Lassus, P., Opitz-Araya, X., & Lazebnik, Y. (2002) · Science · doi:10.1126/science.1074721 · Cited by 719
Defects in regulation of apoptosis in caspase-2-deficient mice
Bergeron, L., Perez, G. I., Macdonald, G., Shi, L., Sun, Y., Jurisicova, A., Varmuza, S., Latham, K. E., Flaws, J. A., Salter, J. C. M., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1304 · Cited by 681
bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia
Hanada, M., Delia, D., Aiello, A., Stadtmauer, E., & Reed, J. (1993) · Blood · doi:10.1182/blood.v82.6.1820.1820 · Cited by 673
Strasser, A. (1994) · Cell · doi:10.1016/0092-8674(94)90201-1 · Cited by 666
Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells
Griffith, T. S., Chin, W. A., Jackson, G. C., Lynch, D. H., & Kubin, M. Z. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.2833 · Cited by 664
Suzuki, Y., Nakabayashi, Y., & Takahashi, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161506698 · Cited by 654
Conradt, B., & Horvitz, H. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81182-4 · Cited by 639
Duckett, C. S., Nava, V. E., Gedrich, R. W., Clem, R. J., Van Dongen, J. L., Gilfillan, M. C., Shiels, H., Hardwick, J. M., & Thompson, C. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00629.x · Cited by 633
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628
Prevention of Programmed Cell Death in Caenorhabditis elegans by Human bcl-2
Vaux, D. L., Weissman, I. L., & Kim, S. K. (1992) · Science · doi:10.1126/science.1470921 · Cited by 618
Self-citationThe MRP family of drug efflux pumps
Kruh, G. D., & Belinsky, M. G. (2003) · Oncogene · doi:10.1038/sj.onc.1206953 · Cited by 614
Apoptosis and the Dilemma of Cancer Chemotherapy
Hannun, Y. A. (1997) · Blood · doi:10.1182/blood.v89.6.1845 · Cited by 605
Marsden, V. S., O'Connor, L., O'Reilly, L. A., Silke, J., Metcalf, D., Ekert, P. G., Huang, D. C. S., Cecconi, F., Kuida, K., Tomaselli, K. J., et al. (2002) · Nature · doi:10.1038/nature01101 · Cited by 578
Self-citationIdentification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
Degterev, A., Lugovskoy, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T., & Yuan, J. (2001) · Nature Cell Biology · doi:10.1038/35055085 · Cited by 550
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zhang, H., Mountz, J. D., Koopman, W. J., Kimberly, R. P., et al. (2001) · Nature Medicine · doi:10.1038/91000 · Cited by 543
Using and Understanding Medical Statistics
Matthews, D. E., Farewell, V. T., & Koss, N. (1987) · Plastic and Reconstructive Surgery · doi:10.1097/00006534-198706000-00033 · Cited by 528
Uren, A. G., Wong, L., Pakusch, M., Fowler, K. J., Burrows, F. J., Vaux, D. L., & Choo, K. H. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00769-7 · Cited by 527
Self-citationChromosomal passengers and the (aurora) ABCs of mitosis
Adams, R. R., Carmena, M., & Earnshaw, W. C. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01880-8 · Cited by 525
Caspase-2 Induces Apoptosis by Releasing Proapoptotic Proteins from Mitochondria
Guo, Y., Srinivasula, S. M., Druilhe, A., Fernandes-Alnemri, T., & Alnemri, E. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108029200 · Cited by 521
Uren, A. G., Pakusch, M., Hawkins, C. J., Puls, K. L., & Vaux, D. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4974 · Cited by 511
Self-citationGenetics of programmed cell death in C. elegans: past, present and future
Metzstein, M. M., Stanfield, G. M., & Horvitz, H. R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01573-x · Cited by 491
Chemosensitisation of malignant melanoma by BCL2 antisense therapy
Jansen, B., Wacheck, V, Heere-Ress, E., Schlagbauer-Wadl, H., Hoeller, C., Lucas, T., Hoermann, M., Hollenstein, U., Wolff, K., & Pehamberger, H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03207-4 · Cited by 482
Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
Reed, J. C. (1995) · Current Opinion in ONCOLOGY · doi:10.1097/00001622-199511000-00012 · Cited by 479
McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K., Green, D., & Cotter, T. (1994) · Blood · doi:10.1182/blood.v83.5.1179.1179 · Cited by 472
Livin, a Novel Inhibitor of Apoptosis Protein Family Member
Kasof, G. M., & Gomes, B. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003670200 · Cited by 454
Waters, J. S., Webb, A., Cunningham, D., Clarke, P. A., Raynaud, F., di Stefano, F., & Cotter, F. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1812 · Cited by 454
Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3
Tzung, S.-P., Kim, K. M., Basañez, G., Giedt, C. D., Simon, J., Zimmerberg, J., Zhang, K. Y. J., & Hockenbery, D. M. (2001) · Nature Cell Biology · doi:10.1038/35055095 · Cited by 452
Dimer formation drives the activation of the cell death protease caspase 9
Renatus, M., Stennicke, H. R., Scott, F. L., Liddington, R. C., & Salvesen, G. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231465798 · Cited by 449
Adrain, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6627 · Cited by 441
Characterization of XIAP-Deficient Mice
Harlin, H., Reffey, S. B., Duckett, C. S., Lindsten, T., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3604-3608.2001 · Cited by 422
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1995) · Nature · doi:10.1038/376596a0 · Cited by 414
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
Vucic, D., Stennicke, H. R., Pisabarro, M. T., Salvesen, G. S., & Dixit, V. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00781-8 · Cited by 414
Robertson, J. D., Enoksson, M., Suomela, M., Zhivotovsky, B., & Orrenius, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204185200 · Cited by 409
Skorski, T., Kanakaraj, P., Nieborowska-Skorska, M., Ratajczak, M., Wen, S., Zon, G., Gewirtz, A., Perussia, B., & Calabretta, B. (1995) · Blood · doi:10.1182/blood.v86.2.726.bloodjournal862726 · Cited by 404
Cell-cycle arrest versus cell death in cancer therapy
Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., & Williams, J. (1997) · Nature Medicine · doi:10.1038/nm0997-1034 · Cited by 389
NADH Oxidase Activity of Mitochondrial Apoptosis-inducing Factor
Miramar, M. D., Costantini, P., Ravagnan, L., Saraiva, L. M., Haouzi, D., Brothers, G., Penninger, J. M., Peleato, M. L., Kroemer, G., & Susin, S. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010498200 · Cited by 388
Byrd, J. C., Kitada, S., Flinn, I. W., Aron, J. L., Pearson, M., Lucas, D., & Reed, J. C. (2002) · Blood · doi:10.1182/blood.v99.3.1038 · Cited by 367
Horita, M., Andreu, E. J., Benito, A., Arbona, C., Sanz, C., Benet, I., Prosper, F., & Fernandez-Luna, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.6.977 · Cited by 366
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
石原, 正. (1997) · Cited by 366
Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse
Kaufmann, S. H., Karp, J. E., Svingen, P. A., Krajewski, S., Burke, P. J., Gore, S. D., & Reed, J. C. (1998) · Blood · doi:10.1182/blood.v91.3.991 · Cited by 365
Self-citationHuang, H.-K., Joazeiro, C. A. P., Bonfoco, E., Kamada, S., Leverson, J. D., & Hunter, T. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61427-4 · Cited by 356
c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release
Juin, P., Hueber, A.-O., Littlewood, T., & Evan, G. (1999) · Genes & Development · doi:10.1101/gad.13.11.1367 · Cited by 335
Interaction between the C. elegans cell-death regulators CED-9 and CED-4
Spector, M. S., Desnoyers, S., Hoeppner, D. J., & Hengartner, M. O. (1997) · Nature · doi:10.1038/385653a0 · Cited by 308
Caspase knockouts: matters of life and death
Zheng, T., Hunot, S., Kuida, K., & Flavell, R. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400593 · Cited by 280
Quantitatively Determined Survivin Expression Levels Are of Prognostic Value in Human Gliomas
Chakravarti, A., Noll, E., Black, P. M., Finkelstein, D., Finkelstein, D. M., Dyson, N. J., & Loeffler, J. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1063 · Cited by 278
Fang, G., Kim, C. N., Perkins, C. L., Ramadevi, N., Winton, E., Wittmann, S., & Bhalla, K. N. (2000) · Blood · doi:10.1182/blood.v96.6.2246 · Cited by 269
Eischen, C. M., Kottke, T. J., Martins, L. M., Basi, G. S., Tung, J. S., Earnshaw, W. C., Leibson, P. J., & Kaufmann, S. H. (1997) · Blood · doi:10.1182/blood.v90.3.935 · Cited by 269
Self-citationCortez, D., Kadlec, L., & Pendergast, A. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5531 · Cited by 267
Arnt, C. R., Chiorean, M. V., Heldebrant, M. P., Gores, G. J., & Kaufmann, S. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207578200 · Cited by 263
Self-citationHolcik, M., Yeh, C., Korneluk, R. G., & Chow, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203765 · Cited by 259
Holtz, M. S., Slovak, M. L., Zhang, F., Sawyers, C. L., Forman, S. J., & Bhatia, R. (2002) · Blood · doi:10.1182/blood.v99.10.3792 · Cited by 253
Translocation of C. elegans CED-4 to Nuclear Membranes During Programmed Cell Death
Chen, F., Hersh, B. M., Conradt, B., Zhou, Z., Riemer, D., Gruenbaum, Y., & Horvitz, H. R. (2000) · Science · doi:10.1126/science.287.5457.1485 · Cited by 243
Clinical applications of TNF-α in cancer
Lejeune, F. J., Rüegg, C., & Liénard, D. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80226-4 · Cited by 243
Bcl-2 and Bcl-XL Can Differentially Block Chemotherapy-Induced Cell Death
Simonian, P. L., Grillot, D. A. M., & Nuñez, G. (1997) · Blood · doi:10.1182/blood.v90.3.1208 · Cited by 242
Ionov, Y., Yamamoto, H., Krajewski, S., Reed, J. C., & Perucho, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190210897 · Cited by 242
The role of the Bcl-2 protein family in cancer
Coultas, L., & Strasser, A. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00129-3 · Cited by 242
Pettitt, A. R., Sherrington, P. D., Stewart, G., Cawley, J. C., Taylor, A. M. R., & Stankovic, T. (2001) · Blood · doi:10.1182/blood.v98.3.814 · Cited by 236
Ryan, A. J., Squires, S., Strutt, H. L., & Johnson, R. T. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.12.3295 · Cited by 227
Amarante-Mendes, G. P., McGahon, A. J., Nishioka, W. K., Afar, D. E., Witte, O. N., & Green, D. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201664 · Cited by 226
Bai, C., Connolly, B., Metzker, M. L., Hilliard, C. A., Liu, X., Sandig, V., Soderman, A., Galloway, S. M., Liu, Q., Austin, C. P., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1230 · Cited by 220
Apoptosis in cancer: cause and cure
Kaufmann, S. H., & Gores, G. J. (2000) · BioEssays · doi:10.1002/1521-1878(200011)22:11<1007::aid-bies7>3.0.co;2-4 · Cited by 214
Self-citationApoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis
Eischen, C. M., Woo, D., Roussel, M. F., & Cleveland, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5063-5070.2001 · Cited by 214
Merritt, A. J., Allen, T. D., Potten, C. S., & Hickman, J. A. (1997) · Oncogene · doi:10.1038/sj.onc.1201126 · Cited by 212
Nicholson, D. W., & Thornberry, N. A. (2003) · Science · doi:10.1126/science.1081274 · Cited by 203
Adult Apaf-1-Deficient Mice Exhibit Male Infertility
Honarpour, N., Du, C., Richardson, J. A., Hammer, R. E., Wang, X., & Herz, J. (2000) · Developmental Biology · doi:10.1006/dbio.1999.9585 · Cited by 203
APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death
Fortin, A., Cregan, S. P., MacLaurin, J. G., Kushwaha, N., Hickman, E. S., Thompson, C. S., Hakim, A., Albert, P. R., Cecconi, F., Helin, K., et al. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105137 · Cited by 194 · cited 19×
“Whether Apaf-1 deficiency also affects long-term viability after drug treatment remains to be determined.”
BackgroundInfluentialLowe, S. W. (1995) · Current Opinion in ONCOLOGY · doi:10.1097/00001622-199511000-00013 · Cited by 194
DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1
Kannan, K., Kaminski, N., Rechavi, G., Jacob‐Hirsch, J., Amariglio, N., & Givol, D. (2001) · Oncogene · doi:10.1038/sj.onc.1204446 · Cited by 189
Zhou, P., Levy, N. B., Xie, H., Qian, L., Lee, C.-Y. G., Gascoyne, R. D., & Craig, R. W. (2001) · Blood · doi:10.1182/blood.v97.12.3902 · Cited by 186
Human Ovarian Cancer and Cisplatin Resistance: Possible Role of Inhibitor of Apoptosis Proteins1
Li, J., Feng, Q., Kim, J.-M., Schneiderman, D., Liston, P., Li, M., Vanderhyden, B., Faught, W., Fung, M. F. K., Senterman, M., et al. (2001) · Endocrinology · doi:10.1210/endo.142.1.7897 · Cited by 185
Neshat, M. S., Raitano, A. B., Wang, H.-G., Reed, J. C., & Sawyers, C. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1179-1186.2000 · Cited by 185
Caspase-2 Can Trigger Cytochrome c Release and Apoptosis from the Nucleus
Paroni, G., Henderson, C., Schneider, C., & Brancolini, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112338200 · Cited by 183
Cell death regulation by the mammalian IAP antagonist Diablo/Smac
Verhagen, A. M., & Vaux, D. L. (2002) · Apoptosis · doi:10.1023/a:1014318615955 · Cited by 175
Self-citationGrotzer, M. A., Eggert, A., Zuzak, T. J., Janss, A. J., Marwaha, S., Wiewrodt, B. R., Ikegaki, N., Brodeur, G. M., & Phillips, P. C. (2000) · Oncogene · doi:10.1038/sj.onc.1203816 · Cited by 174
Generation and Characterization of Smac/DIABLO-Deficient Mice
Okada, H., Suh, W.-K., Jin, J., Woo, M., Du, C., Elia, A., Duncan, G. S., Wakeham, A., Itie, A., Lowe, S. W., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3509-3517.2002 · Cited by 173
Smith, K. G., Strasser, A., & Vaux, D. L. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00901.x · Cited by 169
Self-citationHausmann, G., O’Reilly, L. A., van Driel, R., Beaumont, J. G., Strasser, A., Adams, J. M., & Huang, D. C. S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.3.623 · Cited by 166
Campos, L., Sabido, O., Rouault, J., & Guyotat, D. (1994) · Blood · doi:10.1182/blood.v84.2.595.595 · Cited by 164
Guo, F., Nimmanapalli, R., Paranawithana, S., Wittman, S., Griffin, D., Bali, P., O'Bryan, E., Fumero, C., Wang, H. G., & Bhalla, K. (2002) · Blood · doi:10.1182/blood.v99.9.3419 · Cited by 162
Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1
Moriishi, K., Huang, D. C. S., Cory, S., & Adams, J. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9683 · Cited by 160
Differential Inactivation of Caspase-8 in Lung Cancers
Shivapurkar, N., Toyooka, S., Eby, M. T., Huang, C. X., Sathyanarayana, U. G., Cunningham, H. T., Reddy, J. L., Brambilla, E., Takahashi, T., Minna, J. D., et al. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.1.45 · Cited by 160
Understanding IAP function and regulation: a view from Drosophila
Hay, B. A. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400765 · Cited by 158
Caspase 2 and Caspase 3 Protein Levels as Predictors of Survival in Acute Myelogenous Leukemia
Estrov, Z. E., Thall, P. F., Talpaz, M., Estey, E. H., Kantarjian, H. M., Andreeff, M., Harris, D., Van, Q., Walterscheid, M., & Kornblau, S. M. (1998) · Blood · doi:10.1182/blood.v92.9.3090 · Cited by 156
Rudin, C. M., Otterson, G. A., Mauer, A. M., Villalona-Calero, M. A., Tomek, R. M., Prange, B., George, C., Szeto, L. L., & Vokes, E. E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf124 · Cited by 155
Using and Understanding Medical Statistics.
Osborn, J. F., Matthews, D. E., & Farewell, V. T. (1987) · Biometrics · doi:10.2307/2531975 · Cited by 152
Kyprianou, N., King, E. D., Bradbury, D., & Rhee, J. G. (1997) · International Journal of Cancer · Cited by 147
Chandra, J., Niemer, I., Gilbreath, J., Kliche, K. O., Andreeff, M., Freireich, E. J., Keating, M. J., & McConkey, D. J. (1998) · Blood · doi:10.1182/blood.v92.11.4220 · Cited by 147
Newton, K., & Strasser, A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.195 · Cited by 146
Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas
Shin, M. S., Kim, H. S., Kang, C. S., Park, W. S., Kim, S. Y., Lee, S. N., Lee, J., Park, J. Y., Jang, J. J., Kim, C. W., et al. (2002) · Blood · doi:10.1182/blood.v99.11.4094 · Cited by 142
Martins, L. M., Mesner, P. W., Kottke, T. J., Basi, G. S., Sinha, S., Tung, J. S., Svingen, P. A., Madden, B. J., Takahashi, A., McCormick, D., et al. (1997) · Blood · doi:10.1182/blood.v90.11.4283.4283_4283_4296 · Cited by 139
Self-citationStructural Analysis of a Functional DIAP1 Fragment Bound to Grim and Hid Peptides
Wu, J.-W., Cocina, A. E., Chai, J., Hay, B. A., & Shi, Y. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00282-9 · Cited by 131
Two kinds of BIR-containing protein - inhibitors of apoptosis, or required for mitosis
Silke, J., & Vaux, D. L. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.10.1821 · Cited by 130
Self-citationHoughton, J. A. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199911000-00008 · Cited by 128
Brady, H. J. M., Salomons, G. S., Bobeldijk, R. C., & Berns, A. J. M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00463.x · Cited by 126
Dan, S., Naito, M., & Tsuruo, T. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400400 · Cited by 126
Bcl-2 Family Proteins: Strategies for Overcoming Chemoresistance in Cancer
Reed, J. C. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61070-4 · Cited by 124
Mow, B. M. F., Chandra, J., Svingen, P. A., Hallgren, C. G., Weisberg, E., Kottke, T. J., Narayanan, V. L., Litzow, M. R., Griffin, J. D., Sausville, E. A., et al. (2002) · Blood · doi:10.1182/blood.v99.2.664 · Cited by 119
Self-citationSurvivin does not inhibit caspase-3 activity
Banks, D. P., Plescia, J., Altieri, D. C., Chen, J., Rosenberg, S. H., Zhang, H., & Ng, S. (2000) · Blood · doi:10.1182/blood.v96.12.4002.h8004000c_4002_4003 · Cited by 114
Overexpression of the Bcl-2 Protein Increases the Half-life of p21Bax
Miyashita, T., Kitada, S., Krajewski, S., Horne, W. A., Delia, D., & Reed, J. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26049 · Cited by 105
Bcl-2 Mediates Chemoresistance in Matched Pairs of Primary Eμ-myc Lymphomas in Vivo
Schmitt, C. A., & Lowe, S. W. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0372 · Cited by 104
Rosée, P. G. L., O'Dwyer, M. E., & Druker, B. J. (2002) · Leukemia · doi:10.1038/sj.leu.2402555 · Cited by 104
Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy
Stahnke, K., Fulda, S., Friesen, C., Strauß, G., & Debatin, K. (2001) · Blood · doi:10.1182/blood.v98.10.3066 · Cited by 103
Divinations and Surprises: Genetic Analysis of Caspase Function in Mice
Zheng, T. S., & Flavell, R. A. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4841 · Cited by 100
Kamihira, S., Yamada, Y., Hirakata, Y., Tomonaga, M., Sugahara, K., Hayashi, T., Dateki, N., Harasawa, H., & Nakayama, K. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02902.x · Cited by 97
Apoptosis and the response to anticancer therapy
Mow, B. M. F., Blajeski, A. L., Chandra, J., & Kaufmann, S. H. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00007 · Cited by 96
Self-citationApoptotic Cell Death During Treatment of Leukemias
Li, X., Gong, J., Feldman, E. J., Seiter, K. P., Traganos, F., & Darżynkiewicz, Z. (1994) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199409052678 · Cited by 94
Inactivating mutations of the caspase-10 gene in gastric cancer
Park, W. S., Lee, J., Shin, M. S., Park, J. Y., Kim, H. S., Lee, J. H., Kim, Y. S., Lee, S. H., Xiao, W., Park, C. H., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205394 · Cited by 93
Liu, R., Page, C., Beidler, D. R., Wicha, M. S., & Núñez, G. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65505-8 · Cited by 90
Aebersold, D. M., Kollár, A., Beer, K. T., Laissue, J. A., Greiner, R. H., & Djonov, V. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010220)96:1<41::aid-ijc5>3.0.co;2-f · Cited by 87
Discerning malignancy in adrenocortical tumors: are molecular markers useful?
Wachenfeld, C., Beuschlein, F., Zwermann, O., Mora, P., Faßnacht, M., Allolio, B., & Reincke, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450335 · Cited by 87
Unbound states by analytic continuation in the coupling constant
Tanaka, N., Suzuki, Y., Varga, K., & Lovas, R. (1999) · Physical Review C · doi:10.1103/physrevc.59.1391 · Cited by 85
A Multistep Model for Paclitaxel-Induced Apoptosis in Human Breast Cancer Cell Lines
Blajeski, A. L., Kottke, T. J., & Kaufmann, S. H. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5349 · Cited by 84
Self-citationMeng, X. W., Heldebrant, M. P., & Kaufmann, S. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107218200 · Cited by 83
Self-citationExpression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromes
Boudard, D., Vasselon, C., Berthéas, M., Jaubert, J., Mounier, C., Reynaud, J., Viallet, A., Chautard, S., Guyotat, D., & Campos, L. (2002) · American Journal of Hematology · doi:10.1002/ajh.10108 · Cited by 80
Alterations of Fas-pathway genes associated with nodal metastasis innon-small cell lung cancer
Shin, M. S., Kim, H. S., Lee, S. H., Lee, J. W., Song, Y. H., Kim, Y. S., Park, W. S., Kim, S. Y., Lee, S. N., Park, J. Y., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205527 · Cited by 76
Does Cancer Therapy Trigger Cell Suicide?
Finkel, E. A. (1999) · Science · doi:10.1126/science.286.5448.2256 · Cited by 74
Cited by
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Willis, S. N., Chen, L., Dewson, G., Wei, A., Naik, E., Fletcher, J. I., Adams, J. M., & Huang, D. C. S. (2005) · Genes & Development · doi:10.1101/gad.1304105 · Cited by 1,233
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218
Apoptosis and Molecular Targeting Therapy in Cancer
Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y., & Sakuragi, N. (2014) · BioMed Research International · doi:10.1155/2014/150845 · Cited by 1,121
RetractedThe protein structures that shape caspase activity, specificity, activation and inhibition
FUENTES-PRIOR, P., & SALVESEN, G. S. (2004) · Biochemical Journal · doi:10.1042/bj20041142 · Cited by 880
Metadata
- Authors
- Kaufmann, S. H., & Vaux, D. L.
- Venue
- Oncogene
- Published
- 2003-10-20
- Volume
- 22
- Issue
- 47
- Pages
- 7414-7430
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2080156248
- Cited by
- 265
- References
- 210
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.